FDA Announces Recall of Sterile Compounded Medications Due to Contamination
May 29, 2013
The U.S. Food and Drug Administration (FDA) has announced it is partnering with Main Street Family Pharmacy, LLC in announcing the voluntary recall of all sterile products that were compounded at the facility. The recall is being initiated due to contamination that has led to several patients who used their medications becoming ill.
According to an FDA press release, the company recently received reports of illness from seven patients who were given the company’s preservative-free methylprednisolone acetate injections. The patients stated they had developed abscesses that seem to be fungal in nature at the site of the injection.
The case involves a similar manufacturing process and medication that led to a recent Fungal Meningitis Outbreak that claimed 55 lives and left another 741 patients sickened.
In response to the risk of infection, the FDA has recalled all medications that were manufactured at the manufacturer’s Tennessee facility. Those who are in possession of these products are encouraged to contact Main Street Family Pharmacy. Patients who have used a medication manufactured by the facility and suspect complications have been instructed to contact their healthcare provider and the FDA to report the issues.
The Denver Injury Attorneys with McDivitt Law Firm are aware of the dangers a contaminated medication can cause. The firm is here to help if you have been harmed by a medication given to you by a healthcare provider.Back to the Blog